跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PROMEDYL-B LINCTUS - HSA Drug Approval Details
Approvals
/
HSA
/
PROMEDYL-B LINCTUS
Approved
THERAPEUTIC
PROMEDYL-B LINCTUS
BEACONS PHARMACEUTICALS PTE LTD (SINGAPORE)
🇸🇬 Health Sciences Authority
Approval Date
May 22, 1989
Approval ID
d2c165eac37fe3c7
Company
BEACONS PHARMACEUTICALS PTE LTD (SINGAPORE)
Type
Therapeutic
Approval Details
Approval Id
d2c165eac37fe3c7
Drug Name
PROMEDYL-B LINCTUS
Product Name
PROMEDYL-B LINCTUS
Approval Number
SIN02838P
Approval Date
1989-05-22
Registrant
BEACONS PHARMACEUTICALS PTE. LTD.
Licence Holder
BEACONS PHARMACEUTICALS PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PHARMACY ONLY MEDICINES
Dosage Form
ELIXIR
Route Of Administration
ORAL
Atc Code
R05DA20
Atc Item Name
combinations
Pharma Manufacturer Name
BEACONS PHARMACEUTICALS PTE. LTD.
Active Ingredients
EPHEDRINE HCl
7.2 mg/5 ml
PROMETHAZINE HCl
3.6 mg/5 ml
CODEINE PHOSPHATE
9 mg/5 ml
CODEINE PHOSPHATE
9 MG/5 ML
EPHEDRINE HCL
7.2 MG/5 ML
PROMETHAZINE HCL
3.6 MG/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 22, 1989
Approval ID
d2c165eac37fe3c7
Type
Therapeutic
Back to HSA Approvals